Transaction · 0001663758-26-000002

McCourt Marion

McCourt Marion, EC, reported an open-market or private sale at REGENERON PHARMACEUTICALS, INC. involving 1131.000000 shares for an estimated $969708.09. Reported holdings after the transaction were 12003.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SEC
REGNREGENERON PHARMACEUTICALS, INC.
Filing timeSep 03
Trade dateSep 03, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$843.47
Pre-filing
1mo ago -9.8%1w ago -4.2%1d ago +1.0%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

REGN price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
REGN since 2026-09-03Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001663758-26-000002
Common Stock
Transaction date
Sep 03, 2026
Filed Sep 03, 2026, 08:50 PM · 0d delay
Shares
1.13k sh
$85.7k per share
Estimated value
-$96.9M
Computed from shares × price
Holdings after
12.0k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP Commercial

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 17, 2026.

Original filing · 0001663758-26-000002
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

REGN